Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
LFCR
$6.51
+1.02%
LFCR
· Lifecore Biomedical, Inc. De
$6.51
+0.07 (+1.02%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$243.77M
Shares
37.85M
Volume · Oct 28
364.45K
Avg daily vol (3M)
354.95K
All webcasts
Earnings call · FY2022 Q2
Lifecore Biomedical, Inc. De (LFCR) Q2 2022 Earnings Call
Revenue
$25.60M
+7.6% YoY
Diluted EPS
-$1.31
Gross margin
44.8%
-0.5 pp YoY
Net income
-$38.47M
Forward guidance
5 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Jan 5, 2022.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Consolidated Revenues
full year fiscal 2022
|
$179M – $185M | — | $111.27M below | |
|
Lifecore segment revenue
full year fiscal 2022
|
$105M – $108M | — | — | |
|
Curation Foods segment revenue (as reported)
full year fiscal 2022
|
$261M – $264M | — | — | |
|
Consolidated Adjusted EBITDA
full year fiscal 2022
|
$20.5M – $23M | Non-GAAP | — | |
|
Lifecore segment Adjusted EBITDA
full year fiscal 2022
|
$26M – $27M | Non-GAAP | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Jan 5, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Jan 7, 2022 · complete as-filed document